table of content
1 Introduction to Research & Analysis Reports
1.1 Antisense Oligonucleotide (ASO) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antisense Oligonucleotide (ASO) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antisense Oligonucleotide (ASO) Therapeutics Overall Market Size
2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size: 2022 VS 2032
2.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense Oligonucleotide (ASO) Therapeutics Players in Global Market
3.2 Top Global Antisense Oligonucleotide (ASO) Therapeutics Companies Ranked by Revenue
3.3 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antisense Oligonucleotide (ASO) Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antisense Oligonucleotide (ASO) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense Oligonucleotide (ASO) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Antisense Oligonucleotide (ASO) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Antisense Oligonucleotide (ASO) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Markets, 2022 & 2032
4.1.2 Pulmonary Delivery
4.1.3 Intravenous Injections
4.1.4 Intradermal Injections
4.1.5 Intraperitoneal Injections
4.1.6 Topical Delivery
4.1.7 Others
4.2 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2024-2032
4.2.3 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2022 & 2032
5.1.2 Genetic Disorders
5.1.3 Neurological Disorders
5.1.4 Oncological Disorders
5.1.5 Metabolic Disorders
5.1.6 Ophthalmic Disorders
5.1.7 Others
5.2 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2024-2032
5.2.3 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2022 & 2032
6.2 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2024-2032
6.2.3 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2032
6.3.2 US Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.3.3 Canada Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.3.4 Mexico Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2032
6.4.2 Germany Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4.3 France Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4.4 U.K. Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4.5 Italy Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4.6 Russia Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4.7 Nordic Countries Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.4.8 Benelux Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2032
6.5.2 China Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.5.3 Japan Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.5.4 South Korea Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.5.5 Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.5.6 India Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2032
6.6.2 Brazil Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.6.3 Argentina Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2018-2032
6.7.2 Turkey Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.7.3 Israel Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.7.4 Saudi Arabia Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
6.7.5 UAE Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2018-2032
7 Antisense Oligonucleotide (ASO) Therapeutics Companies Profiles
7.1 Ionis Pharmaceuticals, Inc
7.1.1 Ionis Pharmaceuticals, Inc Company Summary
7.1.2 Ionis Pharmaceuticals, Inc Business Overview
7.1.3 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.1.4 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Ionis Pharmaceuticals, Inc Key News & Latest Developments
7.2 Sarpeta Therapeutics Inc.
7.2.1 Sarpeta Therapeutics Inc. Company Summary
7.2.2 Sarpeta Therapeutics Inc. Business Overview
7.2.3 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.2.4 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Sarpeta Therapeutics Inc. Key News & Latest Developments
7.3 Biogen Inc
7.3.1 Biogen Inc Company Summary
7.3.2 Biogen Inc Business Overview
7.3.3 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.3.4 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Biogen Inc Key News & Latest Developments
7.4 Alnylam Pharmaceuticals, Inc
7.4.1 Alnylam Pharmaceuticals, Inc Company Summary
7.4.2 Alnylam Pharmaceuticals, Inc Business Overview
7.4.3 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.4.4 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Alnylam Pharmaceuticals, Inc Key News & Latest Developments
7.5 Antisense Therapeutics Limited
7.5.1 Antisense Therapeutics Limited Company Summary
7.5.2 Antisense Therapeutics Limited Business Overview
7.5.3 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.5.4 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Antisense Therapeutics Limited Key News & Latest Developments
7.6 Arrowhead Pharmaceuticals Inc.
7.6.1 Arrowhead Pharmaceuticals Inc. Company Summary
7.6.2 Arrowhead Pharmaceuticals Inc. Business Overview
7.6.3 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.6.4 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Arrowhead Pharmaceuticals Inc. Key News & Latest Developments
7.7 Enzon Pharmaceuticals, Inc.
7.7.1 Enzon Pharmaceuticals, Inc. Company Summary
7.7.2 Enzon Pharmaceuticals, Inc. Business Overview
7.7.3 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.7.4 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Enzon Pharmaceuticals, Inc. Key News & Latest Developments
7.8 Bio-Path Holdings, Inc.
7.8.1 Bio-Path Holdings, Inc. Company Summary
7.8.2 Bio-Path Holdings, Inc. Business Overview
7.8.3 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.8.4 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Bio-Path Holdings, Inc. Key News & Latest Developments
7.9 GlaxoSmithKline PLC
7.9.1 GlaxoSmithKline PLC Company Summary
7.9.2 GlaxoSmithKline PLC Business Overview
7.9.3 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.9.4 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline PLC Key News & Latest Developments
7.10 Geron Corporation (Geron)
7.10.1 Geron Corporation (Geron) Company Summary
7.10.2 Geron Corporation (Geron) Business Overview
7.10.3 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
7.10.4 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Geron Corporation (Geron) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
